Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)
at www.tipranks.com (Fri, 25-Sep 1:30 PM)
Biogen’s Diranersen Shows Robust Tau Reduction and Improved Clinical Outcomes in Phase 2 Alzheimer's Trial
Market Chameleon (Tue, 14-Jul 9:44 AM)
